Connecting the CNTNAP2 networks with neurodevelopmental disorders

Molecular Syndromology

Volumn 6, Issue 1, 2015, Pages 7-22

  Poot, Martin ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autism; CNTNAP2; CNV; DNA methylation; Epilepsy; Intellectual delay; Multigenic networks; Neurodevelopmental disorders; Schizophrenia; SNV; Specific language impairment

Indexed keywords

MICRORNA; TRANSCRIPTION FACTOR;

AMYGDALOID NUCLEUS; BRAIN DEVELOPMENT; CONTACTIN ASSOCIATED PROTEIN LIKE 2 GENE; DEVELOPMENTAL DISORDER; DNA METHYLATION; GENE; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENOMICS; HAPLOINSUFFICIENCY; HUMAN; MISSENSE MUTATION; NERVE FIBER; NEURODEVELOPMENTAL DISORDER; NEUROLOGIC DISEASE; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PUTAMEN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE; TRANSGENIC MOUSE;

EID: 84924734076     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000371594     Document Type: Review

References (108)

1. Abrahams BS, Tentler D, Perederiy JV, Oldham MC, Coppola G, Geschwind DH: Genomewide analyses of human perisylvian cerebral cortical patterning. Proc Natl Acad Sci USA 104: 17849-17854 (2007).
2. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, et al: Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism susceptibility gene. Am J Hum Genet 82: 150-159 (2008).
3. Amiel J, Rio M, de Pontual L, Redon R, Malan V, et al: Mutations in TCF4 , encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 80: 988-993 (2007).
4. Anderson GR, Galfin T, Xu W, Aoto J, Malenka RC, Südhof TC: Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc Natl Acad Sci USA 109: 18120-18125 (2012).
5. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, et al: Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet 21: 4781-4792 (2012).
6. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, et al: A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82: 160-164 (2008).
7. Ayub Q, Yngvadottir B, Chen Y, Xue Y, Hu M, et al: FOXP2 targets show evidence of positive selection in European populations. Am J Hum Genet 92: 696-706 (2013).
8. Bailey DB, Lewis MA, Roche M, Powell CM: Family relations in the genomic era: communicating about intergenerational transmission of risk for disability. Fam Rel 63: 85 (2014).
9. Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, et al: Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 82: 165-173 (2008).
10. Ballif BC, Rosenfeld JA, Traylor R, Theisen A, Bader PI, et al: High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. Hum Genet 131: 145-156 (2012).
11. Belloso JM, Bache I, Guitart M, Caballin MR, Halgren C, et al: Disruption of the CNTNAP2 gene in a t(7; 15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet 15: 711-713 (2007).
12. Bertelsen B, Melchior L, Jensen LR, Groth C, Glenthøj B, et al: Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. Eur J Hum Genet 22: 1283-1289 (2014).
13. Boland E, Clayton-Smith J, Woo VG, McKee S, Manson FD, et al: Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet 81: 292-303 (2007).
14. Bragin E, Chatzimichali EA, Wright CF, Hurles ME, Firth HV, et al: DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res 42(Database issue):D993-D1000 (2014).
15. Brockschmidt A, Todt U, Ryu S, Hoischen A, Landwehr C, et al: Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet 16: 1488-1494 (2007).
16. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, et al: Genome-wide analyses of exonic copy number variants in a familybased study point to novel autism susceptibility genes. PLoS Genet 5:e1000536 (2009).
17. Caliebe A, Kroes HY, van der Smagt JJ, Martin- Subero JI, T'nnies H, et al: Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. Eur J Med Genet 53: 179-185 (2010).
18. Chadman KK, Yang M, Crawley JN: Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet 150B:1-11 (2009).
19. Christenhusz GM, Devriendt K, Dierickx K: To tell or not to tell' A systematic review of ethical reflections on incidental findings arising in genetics contexts. Eur J Hum Genet 21: 248-255 (2013).
20. Cooper GM, Stone EA, Asimenos G, NISC Comparative Sequencing Program, Green ED, et al: Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15: 901-913 (2005).
21. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, et al: A copy number variation morbidity map of developmental delay. Nat Ge net 43: 838-846 (2011).
22. Cristino AS, Williams SM, Hawi Z, An JY, Bellgrove MA, et al: Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry 19: 294-301 (2014).
23. Curran S, Bolton P, Rozsnyai K, Chiocchetti A, Klauck SM, et al: No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 156B:633-639 (2011).
24. Denisenko-Nehrbass N, Oguievetskaia K, Goutebroze L, Galvez T, Yamakawa H, et al: Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur J Neurosci 17: 411-416 (2003).
25. Devanna P, Vernes SC: A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep 4: 3994 (2014).
26. De Wolf V, Brison N, Devriendt K, Peeters H: Genetic counseling for susceptibility loci and neurodevelopmental disorders: the del15q11.2 as an example. Am J Med Genet A 161A:2846-2854 (2013).
27. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, et al: Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet 93: 631-640 (2013).
28. Elia J, Gai X, Xie HM, Perin JC, Geiger E, et al: Rare structural variants found in attentiondeficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15: 637-646 (2010).
29. Falivelli G, De Jaco A, Favaloro FL, Kim H, Wilson J, et al: Inherited genetic variants in autism- related CNTNAP2 show perturbed trafficking and ATF6 activation. Hum Mol Genet 21: 4761-4773 (2012).
30. Forrest M, Chapman RM, Doyle AM, Tinsley CL, Waite A, Blake DJ: Functional analysis of TCF4 missense mutations that cause Pitt- Hopkins syndrome. Hum Mutat 33: 1676- 1686 (2012).
31. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13: 261-266 (2008).
32. Ghahramani Seno MM, Hu P, Gwadry FG, Pinto D, Marshall CR, et al: Gene and miRNA expression profiles in autism spectrum disorders. Brain Res 1380: 85-97 (2011).
33. Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19:R176-R187 (2010).
34. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, et al: Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 367: 1321-1331 (2012).
35. Grantham R: Amino acid difference formula to help explain protein evolution. Science 185: 862-864 (1974).
36. Gregor A, Albrecht B, Bader I, Bijlsma EK, Ekici AB, et al: Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 . BMC Med Genet 12: 106 (2011).
37. Gu C, Gu Y: Clustering and activity tuning of Kv1 channels in myelinated hippocampal axons. J Biol Chem 286: 25835-25847 (2011).
38. Hochstenbach R, Buizer-Voskamp JE, Vorstman JAS, Ophoff RA: Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. Cytogenet Genome Res 135: 174- 202 (2011).
39. Horresh I, Poliak S, Grant S, Bredt D, Rasband MN, Peles E: Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons. J Neurosci 28: 14213-14222 (2008).
40. Horresh I, Bar V, Kissil JL, Peles E: Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. J Neurosci 30: 2480-2489 (2010).
41. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, et al: De novo gene disruptions in children on the autistic spectrum. Neuron 74: 285-299 (2012).
42. Ji W, Li T, Pan Y, Tao H, Ju K, et al: CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population. Psychiatry Res 207: 225-228 (2013).
43. Kas MJ, Glennon JC, Buitelaar J, Ey E, Biemans B, et al: Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives. Psychopharmacology (Berl) 231: 1125-1146 (2014).
44. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J: A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46: 310-315 (2014).
45. Koshimizu E, Miyatake S, Okamoto N, Nakashima M, Tsurusaki Y, et al: Performance comparison of bench-top next generation sequencers using microdroplet PCR-based enrichment for targeted sequencing in patients with autism spectrum disorder. PLoS One 8:e74167 (2013).
46. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, et al: Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521 (2012).
47. Lindstrand A, Davis EE, Carvalho CM, Pehlivan D, Willer JR, et al: Recurrent CNVs and SNVs at the NPHP1 locus contribute pathogenic alleles to Bardet-Biedl syndrome. Am J Hum Genet 94: 745-754 (2014).
48. Lou CH, Shao A, Shum EY, Espinoza JL, Huang L, et al: Posttranscriptional control of the stem cell and neurogenic programs by the nonsense- mediated RNA decay pathway. Cell Rep 6: 748-764 (2014).
49. MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW: The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 42:D986-D992 (2013).
50. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488 (2008).
51. Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, et al: Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 6:e1000962 (2010).
52. Mercati O, Danckaert A, André-Leroux G, Bellinzoni M, Gouder L, et al: Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites. Biol Open 2: 324-334 (2013).
53. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, et al: Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am J Med Genet A 155A:2386-2396 (2011).
54. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, et al: Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86: 749-764 (2010).
55. Nava C, Keren B, Mignot C, Rastetter A, Chantot- Bastaraud S, et al: Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders. Eur J Hum Genet 22: 71-78 (2014).
56. Neale BM, Kou Y, Liu L, Maayan A, Samocha KE, et al: Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242-245 (2012).
57. Nestler EJ, Hyman SE: Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161- 1169 (2010).
58. Newbury DF, Monaco AP: Genetic advances in the study of speech and language disorders. Neuron 68: 309-320 (2010).
59. Newbury DF, Fisher SE, Monaco AP: Recent advances in the genetics of language impairment. Genome Med 2: 6 (2010).
60. Newbury DF, Paracchini S, Scerri TS, Winchester L, Addis L, et al: Investigation of dyslexia and SLI risk variants in reading- and languageimpaired subjects. Behav Genet 41: 90-104 (2011).
61. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ: Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6:e1000888 (2010).
62. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, et al: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585-589 (2011).
63. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al: Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246-250 (2012).
64. Panaitof SC, Abrahams BS, Dong H, Geschwind DH, White SA: Language-related Cntnap2 gene is differentially expressed in sexually dimorphic song nuclei essential for vocal learning in songbirds. J Comp Neurol 518: 1995- 2018 (2010).
65. Peippo M, Ignatius J: Pitt-Hopkins syndrome. Mol Syndromol 2: 171-180 (2012).
66. Peñagarikano O, Geschwind DH: What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 18: 156-163 (2012).
67. Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, et al: Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147: 235-246 (2011).
68. Peter B, Raskind WH, Matsushita M, Lisowski M, Vu T, et al: Replication of CNTNAP2 association with nonword repetition and support for FOXP2 association with timed reading and motor activities in a dyslexia family sample. J Neurodev Disord 3: 39-49 (2011).
69. Petrin AL, Giacheti CM, Maximino LP, Abramides DV, Zanchetta S, et al: Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case. Am J Med Genet A 152A:3164-3172 (2010).
70. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB: Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 9:e1003709 (2013).
71. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, et al: Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24: 1037-1047 (1999).
72. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, et al: Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162: 1149-1160 (2003).
73. Poot M: Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders. Mol Syndromol 4: 213-226 (2013).
74. Poot M: A candidate gene association study further corroborates involvement of contactin genes in autism. Mol Syndromol 5: 229-235 (2014).
75. Poot M, Kas MJ: Antisense may make sense of 1q44 deletions, seizures, and HNRNPU . Am J Med Genet A 161A:910-912 (2013).
76. Poot M, Beyer V, Schwaab I, Damatova N, Van't Slot R, et al: Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11: 81-89 (2010).
77. Poot M, van der Smagt JJ, Brilstra EH, Bourgeron T: Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenet Genome Res 135: 228-240 (2011).
78. Prandini P, Pasquali A, Malerba G, Marostica A, Zusi C, et al: The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families. Psychiatr Genet 22: 177-181 (2012).
79. Rodenas-Cuadrado P, Ho J, Vernes SC: Shining a light on CNTNAP2 : complex functions to complex disorders. Eur J Hum Genet 22: 171- 178 (2014).
80. Rosenfeld JA, Ballif BC, Torchia BS, Sahoo T, Ravnan JB, et al: Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet Med 12: 694-702 (2010).
81. Rothwell PE, Fuccillo MV, Maxeiner S, Hayton SJ, Gokce O, et al: Autism-associated neuroligin- 3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 158: 198-212 (2014).
82. Salyakina D, Cukier HN, Lee JM, Sacharow S, Nations LD, et al: Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk. PLoS One 6:e26049 (2011).
83. Sampath S, Bhat S, Gupta S, O'Connor A, West AB, et al: Defining the contribution of CNTNAP2 to autism susceptibility. PLoS One 8:e77906 (2013).
84. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70: 863-885 (2011).
85. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al: De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485: 237-241 (2012).
86. Sarachana T, Zhou R, Chen G, Manji HK, Hu VW: Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med 2: 23 (2010).
87. Schneider E, Jensen LR, Farcas R, Kondova I, Bontrop RE, et al: A high density of human communication-associated genes in chromosome 7q31-q36: differential expression in human and non-human primate cortices. Cytogenet Genome Res 136: 97-106 (2012).
88. Schneider E, El Hajj N, Richter S, Roche-Santiago J, Nanda I, et al: Widespread differences in cortex DNA methylation of the 'language gene' CNTNAP2 between humans and chimpanzees. Epigenetics 9: 533-545 (2014).
89. Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, et al: Recessive symptomatic focal epilepsy and mutant contactinassociated protein-like 2. N Engl J Med 354: 1370-1377 (2006).
90. Thierry G, Beneteau C, Pichon O, Flori E, Isidor B, et al: Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures. Am J Med Genet Part A 158A:1633- 1640 (2012).
91. Toma C, Herv's A, Torrico B, Balmaña N, Salgado M, et al: Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2 . Psychiatr Genet 23: 82-85 (2013).
92. Traka M, Dupree JL, Popko B, Karagogeos D: The neuronal adhesion protein TAG-1 is expressed by Schwann cells and oligodendrocytes and is localized to the juxtaparanodal region in myelinated fibers. J Neurosci 22: 3016-3024 (2002).
93. Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, et al: Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162: 1161-1172 (2003).
94. Tzimourakas A, Giasemi S, Mouratidou M, Karagogeos D: Structure-function analysis of protein complexes involved in the molecular architecture of juxtaparanodal regions of myelinated fibers. Biotechnol J 2: 577-583 (2007).
95. Vaishnavi V, Manikandan M, Tiwary BK, Munirajan AK: Insights on the functional impact of microRNAs present in autism-associated copy number variants. PLoS One 8:e56781 (2013).
96. van Abel D, Michel O, Veerhuis R, Jacobs M, van Dijk M, Oudejans CBM: Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease. J Alzheimer Dis 31: 1-8 (2012).
97. van Bon BW, Koolen DA, Borgatti R, Magee A, Garcia-Minaur S, et al: Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet 45: 346-354 (2008).
98. van Daalen, E, Kemner C, Verbeek NE, van der Zwaag B, Dijkhuizen T, et al: Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism. Neurogenetics 12: 315-323 (2011).
99. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, et al: CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82: 1-9 (2003).
100. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, et al: A functional genetic link between distinct developmental language disorders. N Engl J Med 359: 2337-2345 (2008).
101. Villanueva P, Newbury DF, Jara L, De Barbieri Z, Mirza G, et al: Genome-wide analysis of genetic susceptibility to language impairment in an isolated Chilean population. Eur J Hum Genet 19: 687-695 (2011).
102. Wang X, Xu Q, Bey AL, Lee Y, Jiang Y: Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism 5: 30 (2014).
103. Whalen S, Héron D, Gaillon T, Moldovan O, Rossi M, et al: Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat 33: 64-72 (2012).
104. Whitehouse AJ, Bishop DV, Ang QW, Pennell CE, Fisher SE: CNTNAP2 variants affect early language development in the general population. Genes Brain Behav 10: 451-456 (2011).
105. Won S, Kwon MS, Mattheisen M, Park S, Park C, et al: Efficient strategy for detecting gene gene joint action and its application in schizophrenia. Genet Epidemiol 38: 60-71 (2014).
106. Worthey EA, Raca G, Laffin JJ, Wilk BM, Harris JM, et al: Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech. J Neurodev Disord 5: 29 (2013).
107. Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, et al: Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80: 994-1001 (2007).
108. Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, et al: CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkinslike mental retardation and determine the level of a common synaptic protein in Drosophila . Am J Hum Genet 85: 655-666 (2009).